Team:HKUST-Hong Kong/Module/Anti tumor

From 2012.igem.org

(Difference between revisions)
 
(39 intermediate revisions not shown)
Line 360: Line 360:
-
           <div><p align = "center"><font size="20">ANTI-TUMOR MOLECULE SECRETION</font></p></div>
+
           <div><p align = "center"><font size="20">Anti-tumor Molecule Secretion</font></p></div>
-
<div><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module"><<< Back to Module</a></p></div>
+
<div><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module"><<< Back to Modules</a></p></div>
-
  <div id="paragraph1" class="bodyParagraphs">
+
 
 +
<div id="paragraph1" class="bodyParagraphs">
 +
<div align="left">
 +
<h1><p>Overview</p></h1>
 +
</div>
 +
 
 +
<p>As our team objective is to provide specific and efficient drug delivery against colon cancer, investigating and designing the way of drug synthesis and release is a significant part of our whole project. Hence this module is focusing on the production and delivery of anti-tumor drug. Synthesis of the drug is achieved by engineering bacteria to produce and secrete it. Release of the drug to the extracellular environment is performed by secretion of the recombinant gene product facilitated by attachment of a signaling peptide.<br>
 +
</p>
 +
</div>
 +
 
 +
<div id="paragraph2" class="bodyParagraphs">
           <div align="left">
           <div align="left">
-
               <h1></h1>
+
               <h1><p>Design</p></h1>
           </div>
           </div>
-
          <p>As our team objective is to provide a  specific and efficient drug for Colon cancer, the way of drug synthesis and release is a significant part of our whole project. Hence this module is  focusing on the production and delivery of anti-tumor drug. Synthesis of  the drug is achieved by engineering bacteriawhich is able to produce and secrete anti-tumor  molecule. Release of anti-tumor molecule to extracellular system is attained by  secretion of recombinant gene product under the facilitation of signaling  peptide. </p><br>
+
 
-
<p>Among hundreds of studied anti-tumor chemokine, BMP-2, Bone morphogenetic protein 2 has caught our attention as the &ldquo;drug&rdquo; of our project. BMP-2 is a signaling molecule in BMP pathway, which belongs to the TGF-β superfamily. One function of BMP pathway is to induce cell differentiation, especially in the development of bone and cartilage. BMP stimulates the formation of bone by inducing the cell differentiation of bone cells. On the other hand, BMP-2 has also been suggested to have high apoptotic activity towards colon cancer cells  (Beck <em>et al.,</em> 2005). According to Beck <em>et al.</em>, Colon cancers which are treated with 100 ng/mL BMP-2 for 48 hours show significant decrease in cell growth. Hence, it is a potential drug to fight colon cancer. Therefore, we incorporate mature BMP-2 gene in our construct and transform it into our chosen bacterial vector. </p><br><p>Furthermore, choice of chassis also has important role to ensure the secretion BMP-2. <em>B. subtilis,</em> which is a probiotic, is  chosen as the chassis because of its harmless activity towards human, and high secretory activity which is important for delivery of BMP-2 to the environment. To mimic the secretory activity of <em>B.subtilis</em>, we add signaling peptide type I gene, which works mostly through secretory pathway,  at the upstream of BMP-2 in our construct (Tjalsma <em>et al, </em>2000). That way, signaling peptide is translated together with BMP-2 as a whole peptide, and delivered to the cell membrane. Once it reaches cell membrane, BMP-2 is separated from signaling peptide by signal peptidase (Spase). BMP-2 is then transferred outside the cell and fold into its native conformation, while signal peptide is degraded by signal peptide peptidase (SPPases) (Tjalsma <em>et al, </em>2000). </p><br>
+
<p>Among the hundreds of studied anti-tumor chemokines, BMP2 (bone morphogenetic protein 2) has caught our attention as the &ldquo;drug&rdquo; for our project. BMP2 is a signaling molecule in the BMP pathway, which belongs to the transforming growth factor beta superfamily. One function of the BMP pathway is to induce cell differentiation, especially in the development of bone and cartilage. BMP stimulates the formation of bone by inducing differentiation of bone cells. On the other hand, BMP2 has also been suggested to have high apoptotic activity towards colon cancer cells  (Beck <em>et al.,</em> 2005). According to Beck <em>et al.</em>, colon cancer cells that are treated with 100 ng/mL BMP2 for 48 hours show significant decreases in cell growth. Knowing this fact, we see the potency of BMP2 as the drug to cure colon cancer. Therefore, we incorporate mature BMP2 gene in our construct and transform it into our chosen bacterial vector. <br>
-
<p>However, among hundreds of signaling peptide, we need to choose signaling peptide that allows the secretion of correct mature BMP-2 in appropriate amount. Therefore  we choose YbdN, which is the highest efficiency signaling peptide and YdjM, the  signaling peptide whichsupport accurate cleavage from Spase. . We had not been able to choose between the two choices until we construct two constructs consisting of YdjM or YbdN gene at the upstream of BMP-2 gene and characterize both signaling peptide. </p><br>
+
 
-
<p>Although research has shown  E.coli can produce BMP-2 (Yuvaraj et al, 2012). No one has made a  recombinant protein BMP-2 in B. <em>subtilis</em>. We need to test the function of BMP-2 produced from B. <em>subtilis</em>. This is also the achievement of our group.</p><br>
+
<br>Furthermore, our choice of chassis is also important so we can ensure the secretion of BMP2. <em>B. subtilis</em>, which is a probiotic, was chosen as the chassis because of its harmless activity towards humans and its high secretory activity which is important for the delivery of BMP2 to the environment. To activate the secretory activity of our synthesized BMP2 in <em>B. subtilis</em>, we add signaling peptide type I gene - which works mostly through the <em>B. subtilis'</em> secretory pathway - upstream of the <i>Bmp2</i> gene in our construct (Tjalsma <em>et al., </em>2000). In this way, the signaling peptide would be translated together with BMP2 as a whole peptide, and be delivered to the cell membrane. Once it reaches the cell membrane, BMP2 is separated from the signaling peptide by signal peptidase (Spase). BMP2 is then transferred outside the cell and fold into its native conformation, while the signal peptide is degraded by signal peptide peptidase (SPPases) (Tjalsma <em>et al., </em>2000)<br>
-
<p>&nbsp;</p>
+
 
-
<p>References <br />
+
<p align="center"> <img src="https://static.igem.org/mediawiki/2012/c/c4/Bmp2_2.JPG" width="50%" /></p>
-
  Beck, S. E., Jung, B. H., Fiorino, A., Gomez, J., Del  Rosario, E., Cabrera, B. L., Huang, S. C., Chow, J. Y. C., &amp; Carethers J.M.  (2006). Bone morphogenetic protein signaling and growth suppression in colon  cancer.&nbsp;<em>The American Journal  of Physiology-Gastrointestinal and Liver Physiology</em>,&nbsp;<em>291</em>(1), G135-G145.</p>
+
 
 +
<br>However, among hundreds of signaling peptides, we need to choose the signaling peptide that allows the secretion of the accurate mature BMP2 polypeptide in appropriate amounts. Both YbdN, a signaling peptide of relatively high efficiency in <em>B. subtilis</em>, and YdjM, a peptide supporting reliably accurate cleavage from Spase, looked promising. It would be hard for us to make the decision just based on the literature, so we chose to build the two constructs consisting of <i>ydjM</i> or <i>ybdN</i> gene at the upstream of <i>Bmp2</i> gene and compare them before making the final choice. <br>
 +
 
 +
<br>Although researchers have shown mature BMP2 can be produced in <em>E. coli</em> (Yuvaraj <i>et al.</i>, 2012), recombinant BMP2 has not been successfully expressed in <em>B. subtilis</em>. Also, for the characterization of our work, other than checking whether we successfully produced the recombinant protein, we need to further confirm the function of BMP2 produced by our engineered bacteria.<br>
 +
</p></div>
 +
 
 +
<div id="paragraph3" class="bodyParagraphs">
 +
          <div align="left">
 +
              <h1><p>References</p></h1>
 +
          </div>
 +
 
 +
<p>Beck, S. E., Jung, B. H., Fiorino, A., Gomez, J., Del  Rosario, E., Cabrera, B. L., Huang, S. C., Chow, J. Y. C., &amp; Carethers J.M.  (2006). Bone morphogenetic protein signaling and growth suppression in colon  cancer.&nbsp;<em>The American Journal  of Physiology-Gastrointestinal and Liver Physiology</em>,&nbsp;<em>291</em>(1), G135-G145.</p>
 +
 
<p>Ernesto, C. (2000). &ldquo;Skeletal  Growth Factors&rdquo;. LIPPINCOTT WILLIAMS&amp;WILKINS.</p>
<p>Ernesto, C. (2000). &ldquo;Skeletal  Growth Factors&rdquo;. LIPPINCOTT WILLIAMS&amp;WILKINS.</p>
-
<p>Hardwick,J.C., Van Den Brink,G.R.,  Bleuming,S.A., Ballester,I., Van Den<br />
+
 
-
  Brande,J.M., Keller,J.J.,  Offerhaus,G.J., Van Deventer,S.J., Peppelenbosch,M.P., 2004.<br />
+
<p>Hardwick,J.C., Van Den Brink,G.R.,  Bleuming,S.A., Ballester,I., Van Den Brande,J.M., Keller,J.J.,  Offerhaus,G.J., Van Deventer,S.J., Peppelenbosch,M.P., 2004.Bone morphogenetic protein 2 is  expressed by, and acts upon, mature epithelial cells in the colon. <i>Gastroenterology</i> 2004. Jan. ;126. (1):111.  -21. 126, 111-121. </p>
-
  Bone morphogenetic protein 2 is  expressed by, and acts upon, mature epithelial cells in<br />
+
-
  the colon. Gastroenterology 2004. Jan. ;126. (1):111.  -21. 126, 111-121. </p>
+
<p>Saravanan Yuvaraj, Sa&rsquo;ad H. Al-Lahham, Rajesh Somasundaram,  Patrick A. Figaroa, Maikel P. Peppelenbosch, and Nicolaas A. Bos, <em>E. coli</em>-Produced  BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study.&nbsp;<em>Gastroenterology Research and  Practice</em>, vol. 2012, Article ID 895462, 6 pages, 2012.  doi:10.1155/2012/895462</p>
<p>Saravanan Yuvaraj, Sa&rsquo;ad H. Al-Lahham, Rajesh Somasundaram,  Patrick A. Figaroa, Maikel P. Peppelenbosch, and Nicolaas A. Bos, <em>E. coli</em>-Produced  BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study.&nbsp;<em>Gastroenterology Research and  Practice</em>, vol. 2012, Article ID 895462, 6 pages, 2012.  doi:10.1155/2012/895462</p>
 +
<p>Tjalsma, H., Bolhuis, A., Jongbloed, J. D. H., Bron, S.,  &amp; Dijl, J. M. V. (2000). Signal peptide-dependent protein transport in <i>bacillus subtilis</i>: a genome-based survey of the secretome.&nbsp;<em>Microbiology and Molecular Biology  Reviews</em>,&nbsp;<em>64</em>(3),  515-547.</p>
<p>Tjalsma, H., Bolhuis, A., Jongbloed, J. D. H., Bron, S.,  &amp; Dijl, J. M. V. (2000). Signal peptide-dependent protein transport in <i>bacillus subtilis</i>: a genome-based survey of the secretome.&nbsp;<em>Microbiology and Molecular Biology  Reviews</em>,&nbsp;<em>64</em>(3),  515-547.</p>
-
          </div>
+
 
 +
</div>
 +
 
 +
<div style="clear:both">
<p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Target_binding">Target Binding Module</a></p>
<p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Target_binding">Target Binding Module</a></p>
<p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Regulation_and_control">Regulation and Control Module</a></p>
<p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Regulation_and_control">Regulation and Control Module</a></p>
-
<style type="text/css">
+
</div>
 +
 +
 +
<style type="text/css">
#paragraph1{
#paragraph1{
background-color:#EDFFFF;
background-color:#EDFFFF;
Line 397: Line 424:
border:3px solid #A1FFFF;
border:3px solid #A1FFFF;
border-radius: 10px;
border-radius: 10px;
 +
-moz-border-radius:10px;
 +
}
 +
 +
#paragraph2{
 +
background-color:#FFEDFF;
 +
width:955px;
 +
height:auto;
 +
float:left;
 +
padding-bottom:5px;
 +
padding-left:5px;
 +
margin-top:5px;
 +
margin-bottom:5px;
 +
border:3px solid #FFA1FF;
 +
border-radius: 10px;
 +
-moz-border-radius:10px;
 +
}
 +
 +
#paragraph3{
 +
background-color:#FFFFDD;
 +
width:955px;
 +
height:auto;
 +
float:left;
 +
padding-bottom:5px;
 +
padding-left:5px;
 +
margin-top:5px;
 +
margin-bottom:5px;
 +
border:3px solid #FFFFA1;
 +
border-radius: 10px;
 +
-moz-border-radius:10px;
 +
}
 +
 +
</style>
 +
<div id="Sitemap">
 +
<div id="Sitemap_Home" align="center">
 +
<p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong"><b>Home</b></a></p>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Team</b><p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Introduction">Introduction</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Supervisor">Supervisor</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Instructor">Instructor</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Members">Members</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Advisors">Advisors</a></p></li>
 +
</ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Project</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Project_Abstraction">Abstract</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Background_and_Motive">Motive</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Design_Overview">Design - Overview</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Design_Module">Design - Module</a></p></li>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Target_binding">Target Binding Module</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Anti_tumor">Anti-tumor Molecule Secretion Module</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Regulation_and_control">Regulation and Control Module</a></p>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Design_Chassis">Design - Chassis</a></p></li></ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Wet Lab</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Parts_and_Device">Parts and Devices</a></p></li>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Parts_and_Device">Overview</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Construction">Construction</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Assembly">Assembly</a></p>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Notebook">Notebook</a></p></li>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Notebook/Logbook">Logbook</a></p>
 +
<p>-- <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Notebook/Protocol">Protocol</a></p>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Characterization">Characterization</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Achievement">Achievement</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Future_Work">Future Work</a></p></li></ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Human Practice</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Overview">Overview</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Interview">Interview</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Presentation">Presentation</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Calendar">Calendar</a></p></li></ol>
 +
</div>
 +
<div class="Sitemap_Content">
 +
<li><p><b>Extras</b></p><ol>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Medal_Requirements">Medal Requirements</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Safety">Safety</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Attribution">Attribution</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Acknowledgement">Acknowledgement</a></p></li>
 +
<li><p><a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Glossary">Glossary</a></p></li></ol>
 +
</div>
 +
</div>
 +
<style type="text/css">
 +
#Sitemap{
 +
background-image:url('https://static.igem.org/mediawiki/2012/c/c0/HKUST_Campus.jpg');
 +
background-color:#ffffff;
 +
width:955px;
 +
height:auto;
 +
float:left;
 +
margin-top:5px;
 +
margin-bottom:5px;
 +
padding-bottom:5px;
 +
padding-top:5px;
 +
padding-left:4px;
 +
border:3px solid #000000;
 +
border-radius:10px;
 +
-moz-border-radius:10px;
 +
}
 +
.Sitemap_Content{
 +
background-color:#ffffff;
 +
opacity:0.8;
 +
width:173px;
 +
height:auto;
 +
float:left;
 +
margin:1px;
 +
padding-bottom:5px;
 +
padding-left:5px;
 +
border:3px solid #000000;
 +
border-radius:10px;
 +
-moz-border-radius:10px;
 +
}
 +
#Sitemap_Home{
 +
background-color:#ffffff;
 +
opacity:0.8;
 +
width:940px;
 +
height:auto;
 +
float:left;
 +
margin:1px;
 +
padding-bottom:5px;
 +
padding-left:5px;
 +
border:3px solid #000000;
 +
border-radius:10px;
-moz-border-radius:10px;
-moz-border-radius:10px;
}
}

Latest revision as of 14:13, 21 October 2012

Team:HKUST-Hong Kong - 2012.igem.org

Anti-tumor Molecule Secretion

<<< Back to Modules

Overview

As our team objective is to provide specific and efficient drug delivery against colon cancer, investigating and designing the way of drug synthesis and release is a significant part of our whole project. Hence this module is focusing on the production and delivery of anti-tumor drug. Synthesis of the drug is achieved by engineering bacteria to produce and secrete it. Release of the drug to the extracellular environment is performed by secretion of the recombinant gene product facilitated by attachment of a signaling peptide.

Design

Among the hundreds of studied anti-tumor chemokines, BMP2 (bone morphogenetic protein 2) has caught our attention as the “drug” for our project. BMP2 is a signaling molecule in the BMP pathway, which belongs to the transforming growth factor beta superfamily. One function of the BMP pathway is to induce cell differentiation, especially in the development of bone and cartilage. BMP stimulates the formation of bone by inducing differentiation of bone cells. On the other hand, BMP2 has also been suggested to have high apoptotic activity towards colon cancer cells (Beck et al., 2005). According to Beck et al., colon cancer cells that are treated with 100 ng/mL BMP2 for 48 hours show significant decreases in cell growth. Knowing this fact, we see the potency of BMP2 as the drug to cure colon cancer. Therefore, we incorporate mature BMP2 gene in our construct and transform it into our chosen bacterial vector.

Furthermore, our choice of chassis is also important so we can ensure the secretion of BMP2. B. subtilis, which is a probiotic, was chosen as the chassis because of its harmless activity towards humans and its high secretory activity which is important for the delivery of BMP2 to the environment. To activate the secretory activity of our synthesized BMP2 in B. subtilis, we add signaling peptide type I gene - which works mostly through the B. subtilis' secretory pathway - upstream of the Bmp2 gene in our construct (Tjalsma et al., 2000). In this way, the signaling peptide would be translated together with BMP2 as a whole peptide, and be delivered to the cell membrane. Once it reaches the cell membrane, BMP2 is separated from the signaling peptide by signal peptidase (Spase). BMP2 is then transferred outside the cell and fold into its native conformation, while the signal peptide is degraded by signal peptide peptidase (SPPases) (Tjalsma et al., 2000)


However, among hundreds of signaling peptides, we need to choose the signaling peptide that allows the secretion of the accurate mature BMP2 polypeptide in appropriate amounts. Both YbdN, a signaling peptide of relatively high efficiency in B. subtilis, and YdjM, a peptide supporting reliably accurate cleavage from Spase, looked promising. It would be hard for us to make the decision just based on the literature, so we chose to build the two constructs consisting of ydjM or ybdN gene at the upstream of Bmp2 gene and compare them before making the final choice.

Although researchers have shown mature BMP2 can be produced in E. coli (Yuvaraj et al., 2012), recombinant BMP2 has not been successfully expressed in B. subtilis. Also, for the characterization of our work, other than checking whether we successfully produced the recombinant protein, we need to further confirm the function of BMP2 produced by our engineered bacteria.

References

Beck, S. E., Jung, B. H., Fiorino, A., Gomez, J., Del Rosario, E., Cabrera, B. L., Huang, S. C., Chow, J. Y. C., & Carethers J.M. (2006). Bone morphogenetic protein signaling and growth suppression in colon cancer. The American Journal of Physiology-Gastrointestinal and Liver Physiology291(1), G135-G145.

Ernesto, C. (2000). “Skeletal Growth Factors”. LIPPINCOTT WILLIAMS&WILKINS.

Hardwick,J.C., Van Den Brink,G.R., Bleuming,S.A., Ballester,I., Van Den Brande,J.M., Keller,J.J., Offerhaus,G.J., Van Deventer,S.J., Peppelenbosch,M.P., 2004.Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 2004. Jan. ;126. (1):111. -21. 126, 111-121.

Saravanan Yuvaraj, Sa’ad H. Al-Lahham, Rajesh Somasundaram, Patrick A. Figaroa, Maikel P. Peppelenbosch, and Nicolaas A. Bos, E. coli-Produced BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study. Gastroenterology Research and Practice, vol. 2012, Article ID 895462, 6 pages, 2012. doi:10.1155/2012/895462

Tjalsma, H., Bolhuis, A., Jongbloed, J. D. H., Bron, S., & Dijl, J. M. V. (2000). Signal peptide-dependent protein transport in bacillus subtilis: a genome-based survey of the secretome. Microbiology and Molecular Biology Reviews64(3), 515-547.

Target Binding Module

Regulation and Control Module